Jason Aryeh Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jason Aryeh.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jason Aryeh. Jason Aryeh is Director in LIGAND PHARMACEUTICALS INC ($LGND).
Latest Insider Trading Transactions of Jason Aryeh
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 05 2012 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 11.98 | 700 | 8,386 | 285,036 | 284.3 K to 285 K (+0.25 %) |
May 31 2012 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 12.53 | 7,335 | 91,908 | 7,335 | |
May 31 2012 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 3,592 | 0 | 28,318 | 24.7 K to 28.3 K (+14.53 %) |
May 31 2012 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 2,925 | 0 | 24,726 | 21.8 K to 24.7 K (+13.42 %) |
Nov 10 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 10.90 | 1,000 | 10,900 | 5,025 | 4 K to 5 K (+24.84 %) |
Nov 10 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 11.01 | 1,000 | 11,010 | 284,336 | 283.3 K to 284.3 K (+0.35 %) |
Aug 11 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 10.57 | 2,000 | 21,140 | 283,336 | 281.3 K to 283.3 K (+0.71 %) |
Jun 03 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 10.12 | 7,335 | 74,230 | 7,335 | |
Jun 03 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 4,447 | 0 | 21,801 | 17.4 K to 21.8 K (+25.63 %) |
Jun 03 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 2,925 | 0 | 17,354 | 14.4 K to 17.4 K (+20.27 %) |
May 13 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.75 | 500 | 4,875 | 3,025 | 2.5 K to 3 K (+19.80 %) |
May 13 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.91 | 500 | 4,955 | 2,525 | 2 K to 2.5 K (+24.69 %) |
May 13 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.87 | 500 | 4,935 | 270,111 | 269.6 K to 270.1 K (+0.19 %) |
May 13 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.86 | 500 | 4,930 | 269,611 | 269.1 K to 269.6 K (+0.19 %) |
May 13 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.85 | 500 | 4,925 | 269,111 | 268.6 K to 269.1 K (+0.19 %) |
May 13 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.84 | 500 | 4,920 | 268,611 | 268.1 K to 268.6 K (+0.19 %) |
May 13 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.83 | 500 | 4,915 | 268,111 | 267.6 K to 268.1 K (+0.19 %) |
May 13 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.80 | 500 | 4,900 | 267,611 | 267.1 K to 267.6 K (+0.19 %) |
May 13 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 10.96 | 1,725 | 18,906 | 281,336 | 279.6 K to 281.3 K (+0.62 %) |
Mar 15 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.77 | 500 | 4,885 | 271,111 | 270.6 K to 271.1 K (+0.18 %) |
Mar 15 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.73 | 500 | 4,865 | 270,611 | 270.1 K to 270.6 K (+0.19 %) |
Mar 15 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.72 | 500 | 4,860 | 270,111 | 269.6 K to 270.1 K (+0.19 %) |
Mar 15 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.70 | 500 | 4,850 | 269,611 | 269.1 K to 269.6 K (+0.19 %) |
Mar 15 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.66 | 500 | 4,830 | 269,111 | 268.6 K to 269.1 K (+0.19 %) |
Mar 15 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.63 | 500 | 4,815 | 268,611 | 268.1 K to 268.6 K (+0.19 %) |
Mar 15 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.59 | 500 | 4,795 | 268,111 | 267.6 K to 268.1 K (+0.19 %) |
Mar 16 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.48 | 500 | 4,740 | 276,611 | 276.1 K to 276.6 K (+0.18 %) |
Mar 16 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.46 | 500 | 4,730 | 276,111 | 275.6 K to 276.1 K (+0.18 %) |
Mar 16 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.42 | 500 | 4,710 | 275,611 | 275.1 K to 275.6 K (+0.18 %) |
Mar 16 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.36 | 500 | 4,680 | 275,111 | 274.6 K to 275.1 K (+0.18 %) |
Mar 16 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.31 | 500 | 4,655 | 274,611 | 274.1 K to 274.6 K (+0.18 %) |
Mar 16 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.27 | 500 | 4,635 | 274,111 | 273.6 K to 274.1 K (+0.18 %) |
Mar 16 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.26 | 500 | 4,630 | 273,611 | 273.1 K to 273.6 K (+0.18 %) |
Mar 16 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.25 | 500 | 4,625 | 273,111 | 272.6 K to 273.1 K (+0.18 %) |
Mar 16 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.53 | 500 | 4,765 | 272,611 | 272.1 K to 272.6 K (+0.18 %) |
Mar 16 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.47 | 1,000 | 9,470 | 272,111 | 271.1 K to 272.1 K (+0.37 %) |
Mar 14 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 10.01 | 500 | 5,005 | 3,025 | 2.5 K to 3 K (+19.80 %) |
Mar 14 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 10.08 | 500 | 5,040 | 2,525 | 2 K to 2.5 K (+24.69 %) |
Mar 14 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 10.16 | 500 | 5,080 | 267,611 | 267.1 K to 267.6 K (+0.19 %) |
Feb 23 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.94 | 5,000 | 49,700 | 267,111 | 262.1 K to 267.1 K (+1.91 %) |
Jun 02 2010 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 1.48 | 5,000 | 7,400 | 86,574 | 81.6 K to 86.6 K (+6.13 %) |
May 27 2010 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 1.43 | 15,000 | 21,450 | 15,000 | |
May 27 2010 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 20,979 | 0 | 81,574 | 60.6 K to 81.6 K (+34.62 %) |
May 27 2010 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 5,000 | 0 | 60,595 | 55.6 K to 60.6 K (+8.99 %) |
May 26 2010 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 1.43 | 7,500 | 10,750 | 55,595 | 48.1 K to 55.6 K (+15.59 %) |
May 26 2010 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 1.45 | 2,803 | 4,064 | 48,095 | 45.3 K to 48.1 K (+6.19 %) |
May 24 2010 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 1.48 | 592 | 874 | 45,292 | 44.7 K to 45.3 K (+1.32 %) |
Apr 20 2010 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 2.98 | 15,000 | 44,700 | 15,000 | |
Apr 20 2010 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 5,000 | 0 | 44,700 | 39.7 K to 44.7 K (+12.59 %) |
Page: 1